Porubsky Patrick R, Scott Emily E, Williams Todd D
Department of Medicinal Chemistry, University of Kansas, 1251 Wescoe Hall Dr., Lawrence, KS 66045, USA.
Arch Biochem Biophys. 2008 Jul 1;475(1):14-7. doi: 10.1016/j.abb.2008.03.035. Epub 2008 Apr 7.
Cytochrome P450 2A13 (CYP2A13) is a lung specific enzyme known to activate the potent tobacco procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) into two carcinogenic metabolites. CYP2A13 has been crystallized and X-ray diffraction experiments illuminated the structure of this enzyme, but with an unknown ligand present in the enzyme active site. This unknown ligand was suspected to be indole but a selective method had to be developed to differentiate among indole and its metabolites in the protein sample. We successfully modified a microbiological colorimetric assay to spectrophotometrically differentiate between indole and a number of possible indole metabolites in nanomolar concentrations by derivatization with p-dimethylaminocinnamaldehyde (DMACA). Further differentiation of indoles was made by mass spectrometry (HPLC-UV/vis-MS/MS) utilizing the chromophore generated in the DMACA conjugation as a UV signature for HPLC detection. The ligand in the crystallized protein was identified as unsubstituted indole, which facilitated refinement of two alternate conformations in the CYP2A13 crystal structure active site.
细胞色素P450 2A13(CYP2A13)是一种肺特异性酶,已知可将强效烟草前致癌物4-(甲基亚硝基氨基)-1-(3-吡啶基)-1-丁酮(NNK)激活为两种致癌代谢物。CYP2A13已被结晶,X射线衍射实验阐明了该酶的结构,但酶活性位点存在一个未知配体。这个未知配体被怀疑是吲哚,但必须开发一种选择性方法来区分蛋白质样品中的吲哚及其代谢物。我们成功地改进了一种微生物比色测定法,通过用对二甲基氨基肉桂醛(DMACA)衍生化,以分光光度法区分纳摩尔浓度的吲哚和多种可能的吲哚代谢物。利用DMACA共轭反应中产生的发色团作为HPLC检测的紫外特征,通过质谱(HPLC-UV/vis-MS/MS)进一步区分吲哚。结晶蛋白中的配体被鉴定为未取代的吲哚,这有助于优化CYP2A13晶体结构活性位点中的两种交替构象。